Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Daniel Brock"'
Publikováno v:
Livers, Vol 4, Iss 1, Pp 36-50 (2024)
Artificial Intelligence (AI) can be a useful tool in the management of disease processes such as hepatocellular carcinoma (HCC) as treatment decisions are often complex and multifaceted. AI applications in medicine are expanding with the ongoing adva
Externí odkaz:
https://doaj.org/article/fc6a497f03f546d4adda377e2fb361fc
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
BackgroundMitochondrial health has gained attention in a number of diseases, both as an indicator of disease state and as a potential therapeutic target. The quality and amount of mitochondrial DNA (mtDNA) and RNA (mtRNA) can be important indicators
Externí odkaz:
https://doaj.org/article/f95f801a31164288b07fdf597448c877
Autor:
Katelyn Lewis, BS, Alexandria R. Waler, MD, Daniel Brock, BSME, Rajendra Sawh-Martinez, MD, MHS
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 10S, Pp 138-139 (2021)
Externí odkaz:
https://doaj.org/article/708e6e0dbd36447f94a4fa7bc2fb6077
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hewitt, Daniel Brock1 (AUTHOR), Brown, Zachary J.1 (AUTHOR), Pawlik, Timothy M.1 (AUTHOR) tim.pawlik@osumc.edu
Publikováno v:
Cancers. Oct2022, Vol. 14 Issue 19, p4602. 17p.
Publikováno v:
Livers; Mar2024, Vol. 4 Issue 1, p36-50, 15p
Autor:
Julie K. Johnson, Ryan P. Merkow, Tarik K. Yuce, Daniel Brock Hewitt, Ryan J. Ellis, Christine V. Kinnier, Karl Y. Bilimoria
Publikováno v:
Med Care
BACKGROUND Patient utilization of public reporting has been suboptimal despite attempts to encourage use. Lack of utilization may be due to discordance between reported metrics and what patients want to know when making health care choices. OBJECTIVE
Publikováno v:
Cancer Research. 83:B007-B007
Sarcomas are a diverse group of rare malignant tumors the develop in the bone and connective tissue and are often aggressive with ~50% of patients developing metastases. Due to their rarity and diversity, there is a great lack of standard therapies r
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Surgical Oncology. 28:2931-2933